<HashMap><database>MetabolomicsWorkbench</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>http://www.metabolomicsworkbench.org/rest/study/study_id/ST000771/mwtab</Other></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Metabolomics</omics_type><technology_type>Mass Spectrometry</technology_type><technology_type>ESI</technology_type><species>Homo Sapiens</species><full_dataset_link>http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&amp;StudyID=ST000771</full_dataset_link><study_factor>Transduced with:shACADM4</study_factor><study_factor>Transduced with:shACADMscr</study_factor><study_factor>Transduced with:shACADM6</study_factor><tissue>Cultured Cells</tissue><submitter_affiliation>University of Michigan</submitter_affiliation><sample_protocol>Reversed phase POSITIVE ION MODE.</sample_protocol><repository>MetabolomicsWorkbench</repository><metabolite_name>ARACHIDYL CARNITINE</metabolite_name><metabolite_name>3-HYDROXYLINOLEYLCARNITINE</metabolite_name><metabolite_name>3-HYDROXYPALMITOYLCARNITINE</metabolite_name><metabolite_name>ACETYL-DL-CARNITINE</metabolite_name><metabolite_name>12:1 CARNITINE</metabolite_name><metabolite_name>14:1 CARNITINE</metabolite_name><metabolite_name>L-PALMITOYLCARNITINE</metabolite_name><metabolite_name>AC1MIY4G</metabolite_name><metabolite_name>DL-CARNITINE</metabolite_name><metabolite_name>ARACHIDONYL CARNITINE</metabolite_name><metabolite_name>14:2 CARNITINE</metabolite_name><metabolite_name>LAUROYLCARNITINE</metabolite_name><metabolite_name>OLEOYLCARNITINE</metabolite_name><metabolite_name>DECANOYLCARNITINE</metabolite_name><metabolite_name>8:1 CARNITINE</metabolite_name><metabolite_name>3-HYDROXYMYRISTOYLCARNITINE</metabolite_name><metabolite_name>O-OCTANOYLCARNITINE</metabolite_name><metabolite_name>MYRISTOYLCARNITINE</metabolite_name><metabolite_name>CIS-4-DECENOYL CARNITINE</metabolite_name><metabolite_name>ISOVALERYLCARNITINE</metabolite_name><metabolite_name>LINOELAIDYL CARNITINE</metabolite_name><metabolite_name>11-CIS-ICOSENEOYLCARNITINE</metabolite_name><metabolite_name>(11Z,14Z)-ICOSADIENOYLCARNITINE</metabolite_name><metabolite_name>18:3 CARNITINE</metabolite_name><metabolite_name>3-HYDROXYLAUROYLCARNITINE</metabolite_name><metabolite_name>16:1 CARNITINE</metabolite_name><metabolite_name>GLUTARYLCARNITINE</metabolite_name><metabolite_name>BUTYRYLCARNITINE</metabolite_name><metabolite_name>STEAROYLCARNITINE</metabolite_name><data_protocol></data_protocol><name_synonyms>lipids, MCADH, AU018656, ACAD1., MCAD, Lipid</name_synonyms><sample_synonyms>backward, reversed.</sample_synonyms></additional><is_claimable>false</is_claimable><name>Looking for changes in lipid levels with knock out of ACADM (shACADM)</name><description/><dates><publication></publication></dates><accession>ST000771</accession><cross_references><TAXONOMY>9606</TAXONOMY></cross_references></HashMap>